1). Skinner J. Diagnosis of patent ductus arteriosus. Semin Neonatol. 2001. 6:49–61.
Article
2). El Hajjar M., Vaksmann G., Rakza T., Kongolo G., Storme L. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed. 2005. 90:F419–22.
Article
3). McNamara PJ., Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007. 92:F424–7.
Article
4). Sehgal A., McNamara PJ. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr. 2009. 168:907–14.
Article
5). Sehgal A., Paul E., Menahem S. Functional echocardiography in staging for ductal disease severity: role in predicting outcomes. Eur J Pediatr. 2013. 172:179–84.
6). Su BH., Watanabe T., Shimizu M., Yanagisawa M. Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child Fetal Neonatal Ed. 1997. 77:F36–40.
Article
7). Tavera MC., Bassareo PP., Biddau R., Montis S., Neroni P., Tumbarello R. Role of echocardiography on the evaluation of patent ductus arteriosus in newborns. J Matern Fetal Neonatal Med. 2009. 22(Suppl 3):10–3.
Article
8). Sasi A., Deorari A. Patent ductus arteriosus in preterm infants. Indian Pediatr. 2011. 48:301–8.
Article
9). Choi BM., Lee KH., Eun BL., Yoo KH., Hong YS., Son CS, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics. 2005. 115:e255–61.
Article
10). Shin J., Lee EH., Lee JH., Choi BM., Hong YS. Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants. Korean J Pediatr. 2017. 60:175–80.
Article
11). Su BH., Peng CT., Tsai CH. Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. Arch Dis Child Fetal Neonatal Ed. 1999. 81:F197–200.
Article
12). Su BH., Lin HC., Chiu HY., Hsieh HY., Chen HH., Tsai YC. Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2008. 93:F94–9.
Article
13). Takami T., Yoda H., Kawakami T., Yamamura H., Nakanishi T., Nakazawa M, et al. Usefulness of indomethacin for patent ductus arteriosus in fullterm infants. Pediatr Cardiol. 2007. 28:46–50.
Article
14). Condo M., Evans N., Bellu R., Kluckow M. Echocardiographic assessment of ductal significance: retrospective comparison of two methods. Arch Dis Child Fetal Neonatal Ed. 2012. 97:F35–8.
Article
15). Visconti LF., Morhy SS., Deutsch AD., Tavares GM., Wilberg TJ., Rossi Fde S. Clinical and echocardiographic characteristics associated with the evolution of the ductus arteriosus in the neonate with birth weight lower than 1,500g. Einstein (Sao Paulo). 2013. 11:317–23.
16). Occhipinti F., De Carolis MP., De Rosa G., Bersani I., Lacerenza S., Cota F, et al. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus. J Matern Fetal Neonatal Med. 2014. 27:1800–4.
Article
17). Dix L., Molenschot M., Breur J., de Vries W., Vijlbrief D., Groenendaal F, et al. Cerebral oxygenation and echocardiographic parameters in preterm neonates with a patent ductus arteriosus: an observational study. Arch Dis Child Fetal Neonatal Ed. 2016. 101:F520–6.
Article
18). Lista G., Bianchi S., Mannarino S., Schena F., Castoldi F., Stronati M, et al. Velocity time integral for right upper pulmonary vein in VLBW infants with patent ductus arteriosus. Clinics (Sao Paulo). 2016. 71:580–5.
Article
19). Bapat R., Aggarwal S., Natarajan G. A right-to-left or bidirectional ductal shunt in preterm neonates: grave implication? Am J Perinatol. 2011. 28:709–14.
Article